Last updated on March 2019

A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)

Brief description of study

M2951 is an investigational drug under evaluation for treatment of autoimmune and inflammatory disorders. The purpose of the study is to assess the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE)

Clinical Study Identifier: NCT02975336

Find a site near you

Start Over

Hospital Britanico de Buenos Aires

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Hospital General de Agudos Dr. J. M. Ramos Mejia

Ciudad Autonoma Buenos Aires, Argentina
  Connect »


Ciudad Autonoma Buenos aires, Argentina
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.